Shaozhou K. Tian

Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma–like and Non–Small Cell Carcinoma–like Subsets

Natasha Rekhtman, M. Catherine Pietanza, Matthew D. Hellmann et al. · Clinical Cancer Research · 2016 · 472 citations · Full text

Medicine, Molecular Biology, Oncology +17

Optimizing Workflows and Processing of Cytologic Samples for Comprehensive Analysis by Next-Generation Sequencing: Memorial Sloan Kettering Cancer Center Experience

Shaozhou K. Tian, Jonathan Keith Killian, Natasha Rekhtman et al. · Archives of Pathology & Laboratory Medicine · 2016 · 92 citations · Full text

Medicine, Bioinformatics, Pathology +17

PROTEUS: A randomized, double-blind, placebo (PBO)-controlled, phase 3 trial of apalutamide (APA) plus androgen deprivation therapy (ADT) versus PBO plus ADT prior to radical prostatectomy (RP) in patients with localized high-risk or locally advanced prostate cancer (PC).

Mary‐Ellen Taplin, Martin Gleave, Christopher P. Evans et al. · Journal of Clinical Oncology · 2019 · 17 citations

Medicine, Oncology, Urology +14

Digital Pathology–Based Multimodal Artificial Intelligence Scores and Outcomes in a Randomized Phase III Trial in Men With Nonmetastatic Castration-Resistant Prostate Cancer

Felix Y. Feng, Matthew R. Smith, Fred Saad et al. · JCO Precision Oncology · 2025 · 13 citations

Medicine, Oncology, Urology +17

PROTEUS: A randomized, double-blind, placebo (PBO)-controlled, phase 3 trial of apalutamide (APA) plus androgen deprivation therapy (ADT) versus PBO plus ADT prior to radical prostatectomy (RP) in patients (pts) with localized or locally advanced high-risk prostate cancer (PC).

Adam S. Kibel, Martin Gleave, Sabine Brookman‐May et al. · Journal of Clinical Oncology · 2022 · 10 citations

Medicine, Oncology, Perioperative Medicine +12